Literature DB >> 786035

Lymphotoxin. A review and analysis.

W Rosenau, C D Tsoukas.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 786035      PMCID: PMC2032532     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  69 in total

1.  Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes.

Authors:  S M Walker; S C Lee; Z J Lucas
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  THE SPECIFICITY OF THE CYTOLYTIC EFFECT OF SENSITIZED LYMPHOID CELLS IN VITRO.

Authors:  W ROSENAU; H D MOON
Journal:  J Immunol       Date:  1964-12       Impact factor: 5.422

3.  Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes.

Authors:  J A Green; S R Cooperband; J A Rutstein; S Kibrick
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

4.  Mechanisms of lymphocyte-induced cell and tissue destruction in vitro.

Authors:  G A Granger
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

5.  Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.

Authors:  W P Kolb; G A Granger
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

6.  Quantitative in vitro assay of cytotoxic cellular immunity.

Authors:  T G Canty; J R Wunderlich
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

7.  Lymphokines in the rheumatoid joint.

Authors:  P Stastny; M Rosenthal; M Andreis; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

8.  Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components.

Authors:  S B Salvin; E Ribi; D L Granger; J S Youngner
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes.

Authors:  E W Jeffes; G A Granger
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  7 in total

1.  Target-cell membrane alterations induced by lymphotoxin. Ultrastructural observations.

Authors:  D S Friend; W Rosenau
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

2.  Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro.

Authors:  J H Playfair; J B de Souza; J Taverne
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

3.  Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line.

Authors:  T A Fleisher; W C Greene; T Uchiyama; C K Goldman; D L Nelson; R M Blaese; T A Waldmann
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

4.  Regulatory substances produced by lymphocytes. VI. Cell cycle specificity of inhibitor of DNA synthesis action in L cells.

Authors:  A B Wagshal; B V Jegasothy; B H Waksman
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

5.  Lymphotoxin-induced loss of plasma-membrane protein.

Authors:  W Rosenau; G C Burke; J Moy
Journal:  Am J Pathol       Date:  1979-03       Impact factor: 4.307

6.  Effect of supernatants from PHA-stimulated and non-stimulated lymphocyte cultures on thromboxane B2 release by polymorphonuclear leukocytes in vitro.

Authors:  P Conti; M G Cifone; E Alesse; M Reale; E Boidi; T Williams
Journal:  Agents Actions       Date:  1985-03

7.  Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.

Authors:  C M Zacharchuk; B E Drysdale; M M Mayer; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.